Our management team has a long track record of working successfully in developing pharmaceutical drugs.
Managing Director & Chief Business Officer
Andrea Cusack has 25 years of experience in the pharmaceutical industry and held leading technical and commercial roles in worldwide operating companies at GSK, West Pharmaceutical Services, Archimedes and most recently Catalent, a global leader in the CMO/CDMO business. Andrea joined leon-nanodrugs in June 2018 as Business Development Director and from March 1st 2019 has taken up the role of Managing Director & Chief Business Officer (CBO) of leon-nanodrugs. Andrea holds a Bachelor of Science Honours degree in Chemistry and Polymer Engineering from The University of Cardiff, UK
Managing Director & Chief Financial Officer
Christian Nafe is the Managing Director & Chief Financial Officer of leon-nanodrugs.He brings in more than 25 years of successfully working in corporate finance, controlling and finance. Christian held leading management positions in different roles in worldwide operating companies, since 2000 with a focus on life sciences. During this time, he successfully managed numerous license contracts, asset and share deals as well as supply agreements. He recently served as CEO/CFO at BioNet Holding GmbH, BioNet Ventures GmbH and BioNet Pharma GmbH (former Scil Technology GmbH). Christian graduated with honors as Dipl. Kaufmann in Business Administration from University Regensburg.
Wolfgang Beier, Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Wolfgang Beier is the Chief Scientific Officer and one of the main co-founder of leon-nanodrugs. He has 35 years of international R&D experience in the pharmaceutical industry and in the CRO-business. He held senior executive management R&D positions in various pharma companies (Byk Gulden, Akzo etc.) and he has deep experience with FDA/EMA drug approvals. He focused on drug development in oncology and was a founder and CEO of PFK Pharma Research (CRO), CEO of PFK-ILEX Oncology and co-founder and CEO of Onoclogy World, Munich. Wolfgang holds Ph.D. in Clinical Pharmacology from the University of Hamburg.